Shanghai Yannuo Pharmaceutical Technology
Innovative drug delivery platforms enhancing treatment efficacy and reducing toxicity through advanced lipid and protein carrier technologies.
DDsome operates in the pharmaceutical industry, specializing in advanced drug delivery technologies. The company serves pharmaceutical and biotechnology firms by providing innovative solutions for drug transfer and delivery. DDsome's core offerings include three main drug transfer technology platforms: the Phenomenon Research and Development Platform, the Protein Carrier Research and Development Platform, and the Microball Retardant Research and Development Platform. These platforms focus on gas-based drug development, protein cargo drug development, and microglobular slow-release formulation development. The company also customizes lipids for drug delivery, significantly improving treatment indices and reducing toxicity compared to traditional formulations. DDsome's business model revolves around research and development, partnering with pharmaceutical companies to enhance their drug delivery systems. Revenue is generated through these partnerships, licensing agreements, and the sale of proprietary drug delivery technologies. The market DDsome operates in is highly specialized, targeting firms that require advanced drug delivery solutions to improve the efficacy and safety of their products.
Keywords: drug delivery, lipid customization, protein carriers, microglobular formulations, pharmaceutical R&D, biotechnology, treatment efficacy, toxicity reduction, advanced platforms, proprietary technologies.